TCR-engineered T cell therapy in solid tumors: State of the art and perspectives

Can we predict T cell specificity with digital biology and machine learning?

Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors

Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues